• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[单克隆丙种球蛋白病和多发性骨髓瘤中的肾脏受累]

[Renal involvement in monoclonal gammopathy and multiple myeloma].

作者信息

De Sanctis Lucia Barbara, Sestigiani Elena, Sgarlato Veronica, Fabbrizio Benedetta, Santoro Antonio

机构信息

U.O. Nefrologia, Dialisi Ipertensione, Azienda Ospedaliera-Universitaria ''S. Orsola-Malpighi'', Bologna, Italy.

出版信息

G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S19-33.

PMID:20922692
Abstract

Lymphoproliferative disorders often involve the kidney either by direct cell infiltration (lymphoma) or by deposition of paraproteins (monoclonal gammopathy, multiple myeloma, LCDD, amyloidosis). Nowadays the latter phenomenon seems to be the most common as a result of the growing number of elderly people affected by monoclonal gammopathies. The nephrotoxic potential of monoclonal immunoglobulins and amyloidogenic proteins make monoclonal gammopathies clinical entities of considerable interest in nephrology. Renal involvement presents different clinicomorphological patterns depending on the qualitative and quantitative characteristics of the paraproteins. Tubulointerstitial toxicity is frequent, while vascular and glomerular lesions resulting from non-inflammatory reactions due to immunoglobulin deposition are less common. Acute kidney failure may complicate the clinical course; this could be due to tubular obstruction by paraproteins or to hypovolemia induced by chemotherapy in association with diuretics. Early diagnosis of renal involvement will allow prophylactic interventions to prevent renal complications. At the same time, the increased number of therapeutic tools has enabled better management of kidney complications in lymphoproliferative disorders.

摘要

淋巴增生性疾病常累及肾脏,其途径要么是通过直接细胞浸润(淋巴瘤),要么是通过副蛋白沉积(单克隆丙种球蛋白病、多发性骨髓瘤、轻链沉积病、淀粉样变性)。如今,由于受单克隆丙种球蛋白病影响的老年人数量不断增加,后一种现象似乎最为常见。单克隆免疫球蛋白和淀粉样蛋白生成蛋白的肾毒性潜力使单克隆丙种球蛋白病成为肾脏病学中相当受关注的临床实体。根据副蛋白的定性和定量特征,肾脏受累呈现不同的临床形态学模式。肾小管间质毒性很常见,而由免疫球蛋白沉积引起的非炎症反应导致的血管和肾小球病变则较少见。急性肾衰竭可能使临床病程复杂化;这可能是由于副蛋白导致肾小管梗阻,或者是化疗联合利尿剂引起的血容量不足。肾脏受累的早期诊断将有助于采取预防性干预措施以预防肾脏并发症。与此同时,治疗手段的增加使得能够更好地管理淋巴增生性疾病中的肾脏并发症。

相似文献

1
[Renal involvement in monoclonal gammopathy and multiple myeloma].[单克隆丙种球蛋白病和多发性骨髓瘤中的肾脏受累]
G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S19-33.
2
[Clinical problems in kidney disorders associated with myeloma and other paraproteinemias].
Sb Lek. 1996;97(4):469-77.
3
The ultrastructural basis of renal pathology in monoclonal gammopathies.单克隆丙种球蛋白病肾脏病理的超微结构基础。
J Nephrol. 2005 Nov-Dec;18(6):659-75.
4
New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.与单克隆丙种球蛋白病相关的肾脏疾病发病机制的新进展。
Nephrol Ther. 2015 Jun;11(3):135-43. doi: 10.1016/j.nephro.2014.12.005. Epub 2015 Apr 7.
5
The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.不同临床意义层面单克隆丙种球蛋白病中肾脏受累的范围
Turk J Haematol. 2017 Dec 1;34(4):282-288. doi: 10.4274/tjh.2017.0197. Epub 2017 Aug 23.
6
[Kidney damage in multiple myeloma and other monoclonal gammopathies].[多发性骨髓瘤和其他单克隆丙种球蛋白病中的肾损伤]
Vnitr Lek. 2008 Sep;54(9):847-61.
7
Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.与单克隆免疫球蛋白 M 分泌性 B 细胞淋巴增殖性疾病相关的肾脏疾病:35 例患者的病例系列。
Am J Kidney Dis. 2015 Nov;66(5):756-67. doi: 10.1053/j.ajkd.2015.03.035. Epub 2015 May 16.
8
Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.单克隆丙种球蛋白病和混合性特发性冷球蛋白血症IgG-IgM中的肾小球病变
Adv Nephrol Necker Hosp. 1971;1:161-94.
9
[The kidney in dysproteinemia].[蛋白异常血症中的肾脏]
G Ital Nefrol. 2005 Nov-Dec;22 Suppl 33:S39-45.
10
[Renal involvement in monoclonal gammopathies].
Cas Lek Cesk. 1996 Jun 12;135(12):374-7.